Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a clotting drug cut mastectomy wound drainage?

NCT ID NCT07800832

Disease control Sponsor: Gulab Devi Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests whether applying tranexamic acid directly to the wound during a mastectomy reduces the amount and duration of fluid drainage afterward. Researchers will compare 30 patients who receive the topical drug with 30 who get standard postoperative care. The goal is to see if this simple addition can speed up recovery and lower the risk of wound infection.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tranexamic acid applied directly to the surgical wound
What this could lead to
If it works, this could offer a simple way to reduce wound drainage after mastectomy, potentially leading to faster recovery and fewer complications.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. Tranexamic acid can increase clotting risk, though the trial excludes people with a history of blood clots or clotting disorders.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1\. All patients diagnosed with ductal or lobular breast carcinoma for whom MRM is indicated. Exclusion Criteria: 1. History of thromboembolic events. 2. Patients with coagulation disorders. 3. Currently on anticoagulant therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast carcinoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Effect of topical application of tranexamic acid on wound drainage post modified radical mastectomy

Contacts and locations

Locations

  • Gulab Devi Educational

    Lahore, Punjab Province, Pakistan

  • Gulab Devi hospital

    Lahore, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.